Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
Glob Heart. 2022 Dec 19;17(1):86. doi: 10.5334/gh.1175. eCollection 2022.
Heart failure (HF) has been described as an emerging pandemic as its prevalence continues to rise with a growing and aging population. HF patients are more vulnerable to infections with higher risk of hospitalisation, morbidity, and mortality. During this COVID-19 pandemic, telemedicine has emerged as an alternative to usual out-patient care. This study aimed to systematically review available literature regarding the effect of telemedicine on mortality, health-related quality of life (HR-QoL), and hospitalisation rate of HF patients.
A literature search was conducted on five databases (PubMed, Medline, EMBASE, SCOPUS and Cochrane Central Database) up to 21 May 2022. Data from studies that fulfilled the eligibility criteria were collected and extracted. Included studies were critically appraised using suitable tools and extracted data were synthesized qualitatively.
A total of 27 studies were included in the qualitative synthesis with a total of 21,006 patients and sufficient level of bias. Reduction in the mortality rate, HF-related hospitalisation rate, and improvement in the HR-QoL were shown in most of the studies, although only some were statistically significant.
The use of telemedicine is a promising and beneficial method for HF patients to acquire adequate health care services. Further studies in this field are needed, especially in developing countries and with standardized method, to provide better services and protections for HF patients. Telemonitoring and patient-centred partnership via interactive communication between healthcare team and patients is central to successful telemedicine implementation.
CRD42021271540.
心力衰竭(HF)被描述为一种正在出现的大流行病,因为随着人口的增长和老龄化,其患病率持续上升。HF 患者更容易感染,住院、发病和死亡的风险更高。在 COVID-19 大流行期间,远程医疗已成为常规门诊护理的替代方法。本研究旨在系统回顾有关远程医疗对 HF 患者死亡率、健康相关生活质量(HR-QoL)和住院率影响的现有文献。
在 2022 年 5 月 21 日之前,在五个数据库(PubMed、Medline、EMBASE、SCOPUS 和 Cochrane Central Database)上进行了文献检索。收集符合入选标准的研究数据并进行提取。使用合适的工具对纳入的研究进行批判性评估,并对提取的数据进行定性综合。
共纳入 27 项定性综合研究,共纳入 21006 例患者,偏倚水平足够。大多数研究显示死亡率、HF 相关住院率降低,HR-QoL 改善,但只有部分研究具有统计学意义。
远程医疗是 HF 患者获得足够医疗保健服务的一种有前途且有益的方法。该领域需要进一步研究,特别是在发展中国家,并采用标准化方法,为 HF 患者提供更好的服务和保护。远程监测和以患者为中心的伙伴关系,通过医疗团队和患者之间的互动沟通,是远程医疗成功实施的核心。
PROSPERO 注册号:CRD42021271540。